You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

 

445 Results
Drug
Other Name(s): Neulasta® , Lapelga™ , Fulphila™ , Ziextenzo® , Nyvepria™
Quick Link(s):
Drug Monograph, Patient Info Sheet
Dec 2022
Drug
Other Name(s): Alimta®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Apr 2023
Drug
Quick Link(s):
Drug Monograph, Patient Info Sheet
Feb 2024
Drug
Other Name(s): Matulane®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Dec 2019
Drug
Other Name(s): Taxol®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jun 2024
Drug
Other Name(s): Caelyx®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Dec 2019
Drug
Other Name(s): Perjeta®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Sep 2022
Drug
Other Name(s): Pomalyst®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Aug 2023
Drug
Other Name(s): Iclusig®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Aug 2023
Drug
Other Name(s): Keytruda®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Aug 2023
Drug
Other Name(s): Ibrance™
Quick Link(s):
Drug Monograph, Patient Info Sheet
May 2021
Regimen
Cancer Type:
Central Nervous System
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant, Curative, Palliative
Funding:
ODB - General Benefit
    procarbazine
ODB - General Benefit
    lomustine
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
lomustine,
procarbazine,
vinCRIStine
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jan 2023

Pages